This study elucidates the signaling pathways and specific phosphatases (PP2A and PP2B) responsible for the dephosphorylation and activation of WAVE1, a key regulator of actin polymerization.
Answers are grounded in this paper and cite their sources.
Should not inform clinical decisions; leaves open WAVE1 pathway relevance in human disease.
The Wiskott-Aldrich syndrome protein (WASP)-family verprolin homologous protein 1 (WAVE1) is a key regulator of Arp (actin-related protein) 2/3 complex-mediated actin polymerization. We have established previously that the state of phosphorylation of WAVE1 at three distinct residues controls its ability to regulate actin polymerization and spine morphology. Cyclin-dependent kinase 5 phosphorylates WAVE1 at Ser310, Ser397 and Ser441 to a high basal stoichiometry, resulting in inhibition of WAVE1 activity. Our previous and current studies show that WAVE1 can be dephosphorylated at all three sites and thereby activated upon stimulation of the D1 subclass of dopamine receptors and of the NMDA subclass of glutamate receptors, acting through cAMP and Ca(2+) signaling pathways, respectively. Specifically, we have identified protein phosphatase-2A and protein phosphatase-2B as the effectors for these second messengers. These phosphatases act on different sites to mediate receptor-induced signaling pathways, which would lead to activation of WAVE1.
No takes yet. Share an insight, caveat, or question.
Ceglia et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: